Antiphospholipid antibodies (aPL) are a family of autoantibodies directed against phospholipid-binding plasma proteins, most commonly β 2-glycoprotein-I. Primary thrombosis prevention in ...

To determine the importance of assaying for anti-phospholipid (PL) antibodies other than anti-cardiolipin antibodies in patients with putative anti-phospholipid antibody syndrome (APA), 1,513 ...

Mortality among persistently aPL-positive patients was associated with arterial thrombosis, concomitant systemic autoimmune diseases, and CVD risk factors.

The major emphasis of the Thiagarajan Lab is to elucidate the mechanism of the hypercoagulable state associated with the presence of antiphospholipid antibodies. Patients with systemic lupus ...

If anti-phospholipid antibodies are present, anticoagulants (blood thinning medications) may also help. Transverse myelitis that is related to lupus may relapse once treated, so you should work with ...

Antiphospholipid antibody syndrome (APS) is a rare autoimmune condition that causes thickening of the circulating blood. APS is estimated to affect one in 2,000 people in the United States alone.

In short, Dr. Merrill brings a lifetime of dedication to the management of lupus patients, a contribution to our understanding of anti-phospholipid antibodies, novel design of prospective clinical ...

, Yale University School of Medicine; , St. Mary's Hospital; , Yale University School of Medicine LAC testing is also problematic for the clinician. Not all hospitals and clinical laboratories use ...